Effectiveness of early a-interferon therapy for hepatitis C virus infection recurrence after liver transplantation

Abstract
The results in this short series show that early and prolonged α‐interferon therapy for hepatitis C virus recurrence after liver transplantation could bring some benefit to the infected liver grafts. The risk of graft rejection was clearly minimised by maintaining immunosup‐pression at normal levels.